SEO URLwww.firestrike.ai/deals/novartis-india-chryscapital-acquisition-2026-2
acquisitionAnnounced · Feb 20, 2026PharmaceuticalsSource · CredibleArticle · Factual
ChrysCapital acquires Novartis India
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Novartis India
NSE:NOVARTISIND · Basel, Basel-City
Acquirer
ChrysCapital
Financial Stake
Status
Pending
ChrysCapital agreed to acquire Novartis India. Reported deal value: Undisclosed. Status: Pending. Sector: Pharmaceuticals. Target headquarters context: Basel, Basel-City, Switzerland.
This page summarizes publicly available information about the transaction as of 2026-02-20. Figures and status may change as filings and press coverage update.
Article Novartis India Skyrockets as ChrysCapital Acquires Majority Stake Novartis India shares surged 20% following Novartis AG decision to sell a 70.68% stake to ChrysCapital
Deal timeline
Announced
Feb 20, 2026 · devdiscourse.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals. Figures and status may change as sources update.
Sources: devdiscourse.com · Primary article · FireStrike proprietary index